Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
139.6 INR | +0.40% | +4.72% | +17.25% |
Jul. 07 | Union Bank Gets Sole Counter Bid for Jaypee Health | CI |
Jul. 01 | Union Bank of India Announces Executive Changes | CI |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+17.25% | 12.71B | C- | ||
+25.58% | 598B | C+ | ||
+31.07% | 328B | C+ | ||
+14.40% | 280B | C+ | ||
+22.39% | 196B | C | ||
+17.63% | 183B | B- | ||
+16.78% | 179B | B- | ||
+4.48% | 157B | C+ | ||
+12.76% | 157B | B- | ||
+18.46% | 150B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UNIONBANK Stock
- UNIONBANK Stock
- Ratings Union Bank of India